A new study published in the journal of Molecular Psychiatry found that heparin medication was linked to a delayed diagnosis ...

The number of patients who require maintenance on anticoagulation therapy (warfarin/Coumadin ®) for minimizing risk of cardiovascular events like stroke or thromboembolism is increasing.

Cadrenal Therapeutics, Inc., (Nasdaq: CVKD) (the "Company" or "Cadrenal"), a late-stage biopharmaceutical company developing tecarfarin, a new vitamin K antagonist (VKA) designed to provide safer and ...

Cadrenal Therapeutics, Inc., (Nasdaq: CVKD), a late-stage biopharmaceutical company developing tecarfarin, a new vitamin K antagonist (VKA) anticoagulant, today highlighted a key opinion leader presen ...

No matter whether patients had CAD or not, the simpler regimen was linked to less mortality and major bleeding at 6 months.

Several studies have assessed the use of LMWH for thromboprophylaxis in outpatients with metastatic breast cancer, advanced pancreatic cancer, non-small-cell lung cancer, or grade III-IV malignant ...

Thrombolytics, on the other hand, break up existing blood clots as an emergency therapy. As such, these medications are not taken on a regular basis. Anticoagulants are first-line medications for ...

Uttarakhand government endorses medicinal leech therapy as a non-invasive treatment for post-surgical recovery and skin rejuvenation, amidst growing interest and some controversy.

Left atrial appendage occlusion vs continuation of oral anticoagulation therapy alone is linked to reduced ischemic stroke risk in select patients with nonvalvular AF.

The US Food and Drug Administration granted clearances for various tests for infectious diseases, coagulation disorders, and drug susceptibility.

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

VCM-heparinase was able to reverse heparin effect on viscoelastic parameters during ECMO ... that is focused on improving the safety and availability of blood component therapy. Based in North ...